Previous studies evaluating the association between XPC polymorphisms (Lys939Gln, Val499Arg, and PAT−/+) and gastric cancer risk have provided inconsistent results, and most of these studies involved no more than a few hundred gastric cancer cases, which is too few to assess any genetic effects reliably. This evidence concerns the gene XPC and gastric cancer.